What PE Firms Actually Care About: AR Aging and Billing Automation in Dental M&A
PE Buyers Now Lead with AR Questions
When a private equity firm begins due diligence on a dental practice or DSO, the first financial questions aren't about chair utilization or case acceptance anymore. They're asking about accounts receivable aging, specifically DSO — the number of days it takes to collect payment from insurance and patients after a service is delivered.
That shift happened because AR is a proxy for operational maturity and cash flow stability. A practice with 45-day AR has better cash visibility and lower collection risk than one sitting at 70 days. Acquirers know this isn't just an accounting detail; it's a lead indicator of whether the practice can support debt service post-acquisition.
What the Data Actually Shows
Based on interviews with DSO operators and practice managers, typical dental practice AR ranges between 50 and 75 days, depending on geographic payer mix and billing sophistication. Practices using integrated practice management and claims automation systems consistently report 45–55 day DSO. Those still relying on paper claims, manual insurance follow-up, or fragmented software stacks routinely hit 70+ days.
PE firms have benchmarks now. They know what 45-day AR looks like in your state's payer environment. If you're 20+ days above that benchmark, they'll dig into why — and that investigation often surfaces billing gaps, staff turnover, or legacy workflow problems that cost millions in remediation post-close.
The Billing Stack Audit
Due diligence teams are asking specific, technical questions about your billing infrastructure:
Is your practice management system modern? Systems like Dentrix, EagleSoft, or Open Dental are industry-standard and integrable. Ancient or proprietary systems are red flags — they're expensive to migrate data from and often can't talk to downstream automation tools.
Do you have clearinghouse integration? If your front desk is printing EOBs and manually entering claim status into a spreadsheet, PE buyers see a staffing cost that can be automated away. Integration with vendors like Apex EDI or NEA FastAttach that feed claim status back into your PM system automatically is the baseline expectation now.
Are you using intelligent claims scrubbing? Some practices pre-screen claims for errors before submission. Others don't. Practices using AI-driven claim validation (even basic rule-based logic in their clearinghouse) are showing 5–10% better first-pass acceptance rates, which compresses AR. Acquirers view this as operationalized revenue recovery.
What's your denial management workflow? Do you have a documented process? Is someone assigned to it? PE firms want evidence that denied claims aren't just aging in a folder. Practices with systematic denial review — either in-house or via a vendor partner — are lower risk and show better collections.
Patient Responsibility Is the New Frontier
PE buyers are also looking hard at patient-owed balance management. Insurance payments don't clear AR completely; patient responsibility (copays, deductibles, uninsured balances) often represents 15–30% of total AR depending on the practice's demographics.
Practices that integrate patient billing automation — using vendors like CareCredit, Sunbit, or financing options tied to their PM system — show better patient payment rates and faster cash closure. Practices that don't, and rely on manual patient statements or verbal reminders, leave money on the table and signal weak operations.
Practices also using automated patient payment reminders (text, email, patient portal) via integrated messaging platforms report 10–20% higher collection rates on patient balances, reported by practices in operational reports shared with DSO consolidators.
The Integration Question
Here's the operational reality: disconnected systems drive AR days up. When your PM doesn't talk to your clearinghouse, your clearinghouse doesn't feed claim status back into your system, and your patient messaging platform operates independently, someone is manually reconciling three systems every week. That's delay, error, and staff cost.
PE acquirers are now evaluating integration maturity as a core due diligence metric. Fully integrated stacks (PM → clearinghouse → claims validation → patient messaging) compress AR by 5–15 days within 90 days of standardization, because nothing gets lost in manual handoffs.
This is why they ask about your tech stack before they ask about your hygiene schedules.
What This Means for Your Valuation
AR aging directly affects acquisition multiples. A practice with 50-day DSO might be valued at 6.5× EBITDA. The same practice at 75-day DSO, in the same market, might be valued at 5.8× — a difference of hundreds of thousands of dollars for a $1M+ EBITDA practice.
PE firms justify the discount by modeling the cost to hire billing staff, implement new systems, or use third-party RCM vendors to normalize AR to market benchmarks. If they can see your systems are modern, integrated, and your AR is tight, they price that operational quality into a higher multiple.
Conversely, if you're running legacy billing workflows, manual claim management, and sitting in the high-AR quartile for your market, you're not just carrying a balance sheet problem — you're carrying a valuation penalty.
What to Do Now
If acquisition is even a possibility in your future, audit your billing stack today:
- Document your current DSO. Know the exact number. If it's above your state and payer-mix benchmark, understand why.
- Map your systems. Do your PM, clearinghouse, and patient messaging platforms share data? Or are they separate? Integration is the baseline now.
- Measure first-pass claim acceptance. If you don't know what percentage of claims are accepted on first submission, that's a gap. PE buyers will measure it during diligence.
- Standardize denial management. Assign someone to manage denials systematically. Document it. Show the process.
- Test patient payment workflows. Are patient balances being actively collected? Are you using automated reminders? Integrated financing options?
These aren't nice-to-haves anymore. They're due diligence baselines, and they directly affect what an acquirer will pay for your practice.
The PE firms doing dental acquisitions right now aren't just buying EBITDA. They're buying operational efficiency. Your billing stack is exhibit A.
Related resources
Avized Weekly
Get this kind of analysis every Wednesday.
Independent dental vendor intel — new profiles, comparisons, and market trends.
Browse the full dental AI database
320 vendors profiled, compared, and ranked by data — not marketing spend.
Browse vendors